5 research outputs found
El patrimonio del futuro, una vindicación
El patrimonio cultural contemporáneo configura el paisaje urbano, incide de manera determinante en el hábitat, en la calidad de vida de los pueblos que lo han de disfrutar o ¿soportar¿ durante décadas o siglos y en la formación cultural de los ciudadanos. Descubrir y difundir las nuevas obras del siglo XXI que está creando el ser humano, que no siempre destruye el estado original del mundo sino que también crea e innova y mejora, a través de la arquitectura contemporánea de calidad, el lugar donde vive, y ahondar en las estrategias para ayudar a que lo bueno perdure, a que se valore lo que mejora el mundo en que vivimos, lo excelente de lo que se está haciendo en este momento histórico, e implicar a personas, entidades sociales, empresas, gobiernos, ayuntamientos etc. en la apuesta por la calidad y la excelencia es el reto.Xerach Pérez, D.; Martín Menis, F.; Bosch Reig, I. (2011). El patrimonio del futuro, una vindicación. Arché. (6):489-494. http://hdl.handle.net/10251/34638489494
Bartonella Endocarditis in Spain: Case Reports of 21 Cases
Blood culture negative endocarditis (BCNE) is frequent in infective endocarditis (IE). One of the causes of BCNE is fastidious microorganisms, such as Bartonella spp. The aim of this study was to describe the epidemiologic, clinical characteristics, management and outcomes of patients with Bartonella IE from the “Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España (GAMES)”cohort. Here we presented 21 cases of Bartonella IE. This represents 0.3% of a total of 5590 cases and 2% of the BCNE from the GAMES cohort. 62% were due to Bartonella henselae and 38% to Bartonella quintana. Cardiac failure was the main presenting form (61.5% in B. hensalae, 87.5% in B. quintana IE) and the aortic valve was affected in 85% of the cases (76% in B. henselae, 100% in B. quintana IE). Typical signs such as fever were recorded in less than 40% of patients. Echocardiography showed vegetations in 92% and 100% of the patients with B. henselae and B. quintana, respectively. Culture was positive only in one patient and the remaining were diagnosed by serology and PCR. PCR was the most useful tool allowing for diagnosis in 16 patients (100% of the studied valves). Serology, at titers recommended by guidelines, only coincided with PCR in 52.4%. Antimicrobial therapy, in different combinations, was used in all cases. Surgery was performed in 76% of the patients. No in-hospital mortality was observed. One-year mortality was 9.4%. This article remarks the importance for investigating the presence of Bartonella infection as causative agent in all BCNE since the diagnosis needs specific microbiological tools and patients could benefit of a specific treatment
Aproximación clínica a la eosinofilia importada
Formación médica continuada: Salud internacional y atención al viajero.[EN] Eosinophilia is a common finding in international travelers and immigrants, being an helmintic infection its main etiology. The positive predictive value of eosinophilia for an helmintosis is low in travellers. Eosinophilia may be an incidental finding, or symptomatic, and it represents a clinical challenge due to the low sensitivity and specificity of direct and indirect parasitological diagnostic tests, respectively. It requires a structured approach based on geographical areas, environmental exposures and behavioral risks, and associated symptoms. The initial assessment should include a comprehensive and tailored anamnesis and physical examination, basic laboratory tests, a complete parasitological examination of stool samples and a Strongyloides stercoralis serology, supplemented with other explorations guided by epidemiological and clinical suspicion. Empiric treatment with albendazole and/or ivermectin (plus praziquantel if risk of schistosomiasis) is an option for unidentified persistent eosinophilia after study, and in persons in whom a proper assessment or follow-up can not be assured. In patients at risk for estrongiloidosis who are candidates for immunosuppressive therapies, it is indicated a prior screening and treatment to prevent a future hyperinfestation syndrome.[ES] La eosinofilia es frecuente en viajeros e inmigrantes, siendo las helmintosis su principal etiología. El valor predictivo positivo de la eosinofilia para una infección parasitaria es bajo en viajeros. La eosinofilia puede ser un hallazgo incidental o sintomático, y constituye un reto clínico debido a la baja sensibilidad y especificidad de las técnicas parasitológicas directas e indirectas, respectivamente. Requiere una aproximación estructurada basada en áreas geográficas, riesgos de exposición ambientales y conductuales, y síntomas asociados. La evaluación inicial debe incluir anamnesis y exploración física dirigidas, analítica básica, examen coproparasitológico completo y serología de Strongyloides stercoralis, complementada con otras pruebas según procedencia y sospecha clínica. El tratamiento empírico con albendazol y/o ivermectina (más praziquantel si hay riesgo de esquistosomiasis) es una opción en eosinofilias persistentes no filiadas tras estudio, y en personas en las que la evaluación inicial o el seguimiento no se puedan asegurar. En pacientes con riesgo de estrongiloidosis candidatos a inmunodepresión farmacológica está indicado el cribado y tratamiento previo para prevenir el síndrome de hiperinfestación.Peer reviewe
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective